These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 14966405

  • 1. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, Buechler M, Meuer S.
    Transplantation; 2004 Feb 15; 77(3):339-44. PubMed ID: 14966405
    [Abstract] [Full Text] [Related]

  • 2. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors.
    Giese T, Zeier M, Meuer S.
    Nephrol Dial Transplant; 2004 Jul 15; 19 Suppl 4():iv55-60. PubMed ID: 15240851
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C, Hartschuh W, Enk A, Meuer S, Zeier M, Giese T.
    Clin Transplant; 2008 Jul 15; 22(5):549-54. PubMed ID: 18394001
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
    Sommerer C, Konstandin M, Dengler T, Schmidt J, Meuer S, Zeier M, Giese T.
    Transplantation; 2006 Nov 27; 82(10):1280-5. PubMed ID: 17130775
    [Abstract] [Full Text] [Related]

  • 5. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
    Sommerer C, Morath C, Giese T, Meuer S, Zeier M.
    Transplant Proc; 2008 Jun 27; 40(5):1416-8. PubMed ID: 18589120
    [Abstract] [Full Text] [Related]

  • 6. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M.
    Transplantation; 2008 Jan 15; 85(1):15-21. PubMed ID: 18192906
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a.
    Herden U, Kromminga A, Hagel C, Hartleb J, Nashan B, Sterneck M, Fischer L.
    Ther Drug Monit; 2011 Apr 15; 33(2):185-91. PubMed ID: 21383649
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia.
    Sommerer C, Zeier M, Czock D, Schnitzler P, Meuer S, Giese T.
    Ther Drug Monit; 2011 Aug 15; 33(4):373-9. PubMed ID: 21743376
    [Abstract] [Full Text] [Related]

  • 9. Increased cyclosporin a sensitivity in vivo in pediatric renal transplant recipients compared with adults.
    Billing H, Sommerer C, Giese T, Zeier M, Meuer S, Czock D, Tönshoff B.
    Ther Drug Monit; 2012 Oct 15; 34(5):554-60. PubMed ID: 22929409
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients.
    Konstandin MH, Sommerer C, Doesch A, Zeier M, Meuer SC, Katus HA, Dengler TJ, Giese T.
    Transpl Int; 2007 Dec 15; 20(12):1036-43. PubMed ID: 17850236
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
    Billing H, Breil T, Schmidt J, Tönshoff B, Schmitt CP, Giese T, Engelmann G.
    Pediatr Transplant; 2012 Mar 15; 16(2):187-94. PubMed ID: 22360403
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K, Gotthardt D, Giese T, Schnitzler P, Stremmel W, Czock D, Eisenbach C.
    Liver Transpl; 2014 Sep 15; 20(9):1106-17. PubMed ID: 24890314
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older.
    Sommerer C, Schnitzler P, Meuer S, Zeier M, Giese T.
    Ther Drug Monit; 2011 Dec 15; 33(6):694-8. PubMed ID: 22105585
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients.
    Billing H, Giese T, Sommerer C, Zeier M, Feneberg R, Meuer S, Tönshoff B.
    Pediatr Transplant; 2010 Nov 15; 14(7):844-51. PubMed ID: 20602720
    [Abstract] [Full Text] [Related]

  • 15. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C, Zeier M, Meuer S, Giese T.
    Transplantation; 2010 Jun 15; 89(11):1417-23. PubMed ID: 20463649
    [Abstract] [Full Text] [Related]

  • 16. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
    Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A.
    Transpl Infect Dis; 2014 Jun 15; 16(3):379-86. PubMed ID: 24666466
    [Abstract] [Full Text] [Related]

  • 17. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 18. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
    Kiani A, Habermann I, Haase M, Feldmann S, Boxberger S, Sanchez-Fernandez MA, Thiede C, Bornhäuser M, Ehninger G.
    J Leukoc Biol; 2004 Nov 15; 76(5):1057-65. PubMed ID: 15292278
    [Abstract] [Full Text] [Related]

  • 19. Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: the first clinical trial in liver allograft recipients.
    Zahn A, Schott N, Hinz U, Stremmel W, Schmidt J, Ganten T, Gotthardt D, Meuer S, Zeier M, Giese T, Sommerer C.
    Liver Transpl; 2011 Apr 15; 17(4):466-73. PubMed ID: 21445930
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A.
    Sommerer C, Zeier M, Meuer S, Giese T.
    Clin Nephrol; 2015 Sep 15; 84(3):165-72. PubMed ID: 26226950
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.